1.Research progress on the relationship between Porphyromonas gingivalis and oral squamous cell carcinoma.
Wu-chao WU ; Yafei WU ; Lei ZHAO
West China Journal of Stomatology 2015;33(6):651-655
Substantial evidence supports the relationship between chronic inflammation and cancer development. Numerous studies suggest that chronic inflammatory disease, such as periodontitis, contributes to head and neck squamous cell carcinoma development. Oral squamous cell carcinoma (OSCC) is the most common malignant tumor in the oral and maxillofacial regions. Porphyromonas gingivalis, one of the most important pathogens in association with periodontal disease, might have a potential correlation with OSCC. Along with the development of molecular biological techniques, the association between Porphyromonas gingivalis and OSCC has been greatly emphasized in recent years. This review summarizes the association between these variables and the potential mechanisms involved in such relationship.
Carcinoma, Squamous Cell
;
pathology
;
Humans
;
Mouth Neoplasms
;
pathology
;
Periodontal Diseases
;
Periodontitis
;
Porphyromonas gingivalis
;
Research
3.Second thoughts on metabolic syndrome.
Chinese Journal of Epidemiology 2006;27(12):1017-1018
4.Effects of Combined Telmisartan and Ramlpril on Heart Function and Renin-angiotensin-aldosterone System and Ventricle Remodeling in Patients with Chronic Congestive Heart Failure
Journal of Medical Research 2009;38(8):36-39
Objective To study the effects of combined telmisartan and ramiprll on heart function and renin - angiotensin - aldoste-tone system and ventricle remodeling and brain natriuretie peptide in patients with chronic heart failure (CHF). Methods 100 patientswith chronic heart failure were randomly divided into three groups: telmisartan group (A group, treated with telmisartan 80mg once daily, n =33), ramipril group (B group treated with ramipril 5mg once daily, n =33) and telmisartan plus ramipril group (treated with telmis-artan 40mg plus ramipril 2.5mg once daily, n = 34). Left ventricular end - diastolic dimensions (LVEDD) and left ventricular ejection fraction (LVEF) were assessed, and plasma renin activity (Ren) , angiotensinIl (Angll), aldosterone (Aid) and brain natriuretic pep-tide (BNP) were measured before and after therphy. Results After 6 months of treatment, LVEDD and LVEF were improved in all groups(P < 0.01). All changs were significant in C group than those in A group or B group(P < 0.01). The concentration of Ren were in-creased in all groups(P <0.01). The concentration of Angll was increased in A group and decreased in B group(P <0.01)while there was no difference at pre or post treatment in C group (P > 0.01). The concentration of Ald and BNP was decreased in all groups (P < 0.01). Ald and BNP were decreased more significantly in C group than those in A group or B group. Conclusion Combination of low dose of telmisartan and ramipril therapy has more benificial clinical features than telmisartan or ramipril alone in patients with CHF.
5.Effects of Combined Telmisartan and Ramipril on Heart Function and Renin-angiotensin-aldosterone System and Ventricle Remodeling in Patients with Chronic Congestive Heart Failure
Journal of Medical Research 2006;0(08):-
Objective To study the effects of combined telmisartan and ramipril on heart function and renin-angiotensin-aldosterone system and ventricle remodeling and brain natriuretic peptide in patients with chronic heart failure(CHF).Methods 100 patients with chronic heart failure were randomly divided into three groups: telmisartan group(A group,treated with telmisartan 80mg once daily,n=33),ramipril group(B group treated with ramipril 5mg once daily,n=33) and telmisartan plus ramipril group(treated with telmisartan 40mg plus ramipril 2.5mg once daily,n=34).Left ventricular end-diastolic dimensions(LVEDD) and left ventricular ejection fraction(LVEF) were assessed,and plasma renin activity(Ren),angiotensinII(AngII),aldosterone(Ald) and brain natriuretic peptide(BNP) were measured before and after therphy.Results After 6 months of treatment,LVEDD and LVEF were improved in all groups(P0.01).The concentration of Ald and BNP was decreased in all groups(P
6.Difference of ?-tubulin and aurora-A expression in human cervical cancer and H8 cells
Journal of Third Military Medical University 2003;0(13):-
Objective To compare and analyze the difference of ?-tubulin and aurora-A expression in human cervical cancer cells (CasKi ) and immortalized human cervical squamous H8 cells with positive HPV16 E6E7.Methods Difference of ?-tubulin and aurora-A expression in CasKi and H8 cells was analyzed by showing the fluorescence intensity of ?-tubulin with indirect immunofluorescence.Expression level of aurora-A mRNA was detected by RT-PCR.Expression level of ?-tubulin and aurora-A in CasKi and H8 cells was semi-quantitatively analyzed by Western blot.Results The immunofluorescence signal of ?-tubulin was stronger in Caski cells than in H8 cells (57.78?3.13 vs 37.37?2.37,P
7.CIRCADIAN VARIATIONS OF PITUITARY ?-ENDORPHIN-LIKE IMMUNOREACTIVITY AND ITS RELATIONSHIP TO THE PAIN THRESHOLD IN RATS
Acta Anatomica Sinica 1953;0(01):-
Immunohistochemical method, immuno-electron microscopic technique and radioimmunoassay (RIA) were used for the demonstration of ?-endorphin-like immunoreactivity (?-EP-IR) and of the circadian variation of the ?-EP-IR level in rat pituitary. ?-ER-IR was located in all cells of the pituitary intermediate lobe. A few ?-ER-IR-positive cells were scattered in the anterior lobe, and no positive immunoreactivity was found in the posterior lobe. The controls were negative. Under electron microscope, ?-ER-IR-positive dense particles were mostly located in the secretion granules, and a few of them were scattered freely in the cytoplasm of the intermediate lobe cells. Both pituitary ?-EP-IR concentration and the basal pain threshold in rat showed circadian variations in the experiment done at 4-hr intervals over a 24-hr period (P
8.Clinical application and prospect of bone marrow stem cells for myocardial infarction
Chinese Journal of Tissue Engineering Research 2007;0(03):-
BACKGROUND:At present,application revascularization and drug treatment may arrest aggravation of heart function and arrhythmic development,but effectiveness is limited.Infarcted myocardial cells are still impossible to regenerate.How to make necrotic myocardial cell regeneration and diastolic myocardial function is the problem to solve.OBJECTIVE:To analyze the study progress of bone marrow stem cells in treatment of myocardial infarction.RETRIEVAL STRATEGY:A computerized online database of Pubmed was searched to identify articles published from May 2000 to July 2006 with the key words of "the marrow stem-cell,cell transplant,myocardial infarction" in English.Simultaneously,articles published between October 1997 and December 2006 were identified in China Journal Full-text Database with the same key word in Chinese.Sixty-seven articles were retrieved and data were selected primarily.Inclusive criteria:①articles related to the transplantation of bone marrow stem cells for the treatment of myocardial infarction,②in the same field,articles recently published or in authoritative journals.Exclusive criteria:①articles of repetitive study,and ②Meta analysis.LITERATURE EVALUATION:Articles mainly analyzes the transplantation of stem cells for the treatment of myocardial infarction.Of the 30 included articles,10 were reviews and the rest was clinical or basic studies.DATA SYNTHESIS:①Bone marrow stem cells are composed of bone marrow mononuclear cells,hematopoietic stem cells,bone marrow mesenchymal stem cells,endothelial stem/progenitor cells,multipotent adult progenitor cells and so on.②After the transplantation,bone marrow stem cells can differentiate into myocardiocytes,and do effectively electromechanical coupling with receptors.Bone marrow stem cells can promote the angiogenesis in ischemic region,avoid ethical dispute and immunological rejection,and these cells are easy to collect.Bone marrow stem cells are adult stem cells,and its transdifferentiation deserves further study.Many clinical studies showed that autogeneic bone marrow stem cell transplantation for the treatment of acute myocardial infarction and heart failure could be achieved.③Matrix metalloproteinase,stem cell factor and stromal cell chemokine from bone marrow stem cells play important roles in stem cell mobilization,homing and myocardial repair.Tissue injury and high-level multipotential stem cells are two key factors of the differentiation of bone marrow stem cells in myocardial microenvironment.④ Problems in bone marrow stem cell transplantation included cell type,regulatory mechanism of transdifferentiation,optimal time,manner and safety of transplantation,etc.CONCLUSION:Through establishing complete animal model,the possibility of each technique in clinical procedures is explored.Bone marrow stem cells in treatment of acute myocardial infarction may become a new method,which has different from traditional drug treatment,interventional therapy of cardiovascular disease and surgical intervention.
9.Application management of surgical instrument
Chinese Medical Equipment Journal 1989;0(01):-
The application management of surgical instrument is introduced from five aspects including risk control, operation rules, quality inspection and metering management, periodical maintenance and prompt service.
10.Device for Endothelium Dysfunction Detection Based on Photoplethysmographic Method
Chinese Medical Equipment Journal 2004;0(07):-
Objective To evaluate endothelium dysfunction of arteries for early preventing atherosis. Methods A new portable device for detection of endothelium dysfunction by photoplethysmographic method was designed, which depended on the principle of reactive hyperaemia. Results Experiments between hypertensive and normotensive showed that different degree endothelium dysfunction had emerged among hypertensive. Conclusion The proposed device has potential benefit to research, diagnosis and therapy evaluation for subclinic arterial disease.
Result Analysis
Print
Save
E-mail